Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R Jackson

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Regulatory Peptides|July 2, 1993
Differential SAR of quinuclidine SP antagonists between rat and human-type receptorsR M Snider, K P Longo, S H Zorn, et al.
Journal of Medicinal Chemistry|July 10, 1992
The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1- azabicyclo[2.2.2]-octan-3-amine as a novel, nonpeptide substance P antagonisstJ A Lowe, S E Drozda, R M Snider, et al.
Regulatory Peptides|July 2, 1993
Discovery of CP-96,345 and its characterization in disease models involving substance PJ A Lowe, S E Drozda, R M Snider, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 1, 1988
Trends in invasive treatment of single-vessel and double-vessel coronary diseaseJ M Arcidi, S W Powelson, S B King, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis, SAR and pharmacology of CP-293,019: a potent, selective dopamine D4 receptor antagonistM A Sanner, T A Chappie, A R Dunaiskis, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Regulatory Peptides|July 2, 1993
Differential SAR of quinuclidine SP antagonists between rat and human-type receptorsR M Snider, K P Longo, S H Zorn, et al.
Journal of Medicinal Chemistry|July 10, 1992
The discovery of (2S,3S)-cis-2-(diphenylmethyl)-N-[(2-methoxyphenyl)methyl]-1- azabicyclo[2.2.2]-octan-3-amine as a novel, nonpeptide substance P antagonisstJ A Lowe, S E Drozda, R M Snider, et al.
Regulatory Peptides|July 2, 1993
Discovery of CP-96,345 and its characterization in disease models involving substance PJ A Lowe, S E Drozda, R M Snider, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 1, 1988
Trends in invasive treatment of single-vessel and double-vessel coronary diseaseJ M Arcidi, S W Powelson, S B King, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis, SAR and pharmacology of CP-293,019: a potent, selective dopamine D4 receptor antagonistM A Sanner, T A Chappie, A R Dunaiskis, et al.
Pageof 3